Triethylene Glycol

Triethylene Glycol

SCHEMBL273265

CCOC(C)=O.CCOCC.OCCOCCOCCO

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
TSHR P16473 3/20 0.59
HSD17B10 Q99714 2/20 0.58
LMNA P02545 1/20 0.58
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
THRB P10828 2/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
GAA P10253 2/20 0.37
ALOX15 P16050 1/20 0.34
MGAM O43451 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL2702054 1.00 ALDH1A1 (0.59) ALDH1A1TSHRHSD17B10LMNAKMT2A
Di(Hydroxyethyl)Ether SCHEMBL181560 0.98 ALDH1A1 (0.61) ALDH1A1TSHRHSD17B10LMNAKMT2A
Diethylene Glycol Monoethyl Ether SCHEMBL10628086 0.96 ALDH1A1 (0.61) ALDH1A1TSHRHSD17B10LMNAKMT2A
Diethylene Glycol Monoethyl Ether SCHEMBL6899107 0.96 ALDH1A1 (0.65) ALDH1A1TSHRHSD17B10LMNAKMT2A
Tetraethylene Glycol SCHEMBL16143312 0.96 ALDH1A1 (0.64) ALDH1A1TSHRHSD17B10LMNAKMT2A
Ethyl Acetate SCHEMBL10623401 0.94 ALDH1A1 (0.61) ALDH1A1TSHRHSD17B10LMNAKMT2A
Di(Hydroxyethyl)Ether SCHEMBL566173 0.94 ALDH1A1 (0.67) ALDH1A1TSHRHSD17B10LMNAKMT2A
Triethylene Glycol SCHEMBL925608 0.93 ALDH1A1 (0.52) ALDH1A1TSHRHSD17B10LMNAKMT2A
Ether SCHEMBL243266 0.92 ALDH1A1 (0.72) ALDH1A1TSHRHSD17B10LMNAKMT2A
Ether SCHEMBL1401416 0.92 ALDH1A1 (0.72) ALDH1A1TSHRHSD17B10LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115895377-B Solvent type high refractive index composition and application thereof in OLED display device 西安思摩威新材料有限公司 2023-11-24 CN claimed
CN-115895377-A Solvent type high-refractive-index composition and application thereof in OLED display device 西安思摩威新材料有限公司 2023-04-04 CN claimed
CN-102453149-A Olefin polymerization catalyst component, olefin polymerization catalyst, and olefin polymerization method CHINA PETROLEUM & CHEMICAL 2012-05-16 CN claimed
US-20060011584-A1 Etchant and etching method DAIKIN INDUSTRIES, LTD. (JP) 2006-01-19 US claimed
EP-1538664-A1 ETCHANT AND ETCHING METHOD Daikin Industries, Ltd. (JP) 2005-06-08 EP claimed
US-12630727-B2 Photocurable inkjet printing ink composition SAKATA INX CORPORATION (JP) 2026-05-19 US disclosed
CN-122029488-A Photosensitive coloring composition, cured product, partition wall, organic electroluminescent element, color filter, and image display device 三菱化学株式会社 2026-05-12 CN disclosed
US-20260125594-A1 QUANTUM DOT-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-05-07 US disclosed
US-12588446-B2 Surface treatment composition and method for producing wafer CENTRAL GLASS COMPANY, LIMITED (JP) 2026-03-24 US disclosed
US-12570865-B2 Active energy ray-curable inkjet printing ink composition SAKATA INX CORPORATION (JP) 2026-03-10 US disclosed
EP-4700824-A1 LOW-TEMPERATURE-SINTERING BONDING MATERIAL AND BONDED STRUCTURE Daicel Corporation (JP) 2026-02-25 EP disclosed
US-20260018421-A1 SUBSTRATE PROCESSING METHOD, AND SUBSTRATE MANUFACTURING METHOD CENTRAL GLASS CO LTD (JP) 2026-01-15 US disclosed
EP-0768573-A1 Phosphor-containing photosensitive resin composition for use in manufacturing plasma display panel Hitachi Chemical Co., Ltd. (JP) 1997-04-16 EP disclosed
US-4863835-A UNSATURATED POLYESTER, BENZYL ALCOHOL, TETRAHYDROFURFURYL ALCOHOL, ACID MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1989-09-05 US disclosed
EP-0037179-B1 DEVELOPER COMPOSITION FOR LITHOGRAPHIC PRINTING PLATES, A METHOD OF PLATE DEVELOPMENT, AND DEVELOPED PLATES MITSUBISHI KASEI CORPORATION (JP) 1985-05-29 EP disclosed
EP-0013006-B1 DEVELOPER COMPOSITION FOR LITHOGRAPHIC PRINTING PLATES MITSUBISHI KASEI CORPORATION (JP) 1983-06-22 EP disclosed
EP-0037179-A2 Developer composition for lithographic printing plates, a method of plate development, and developed plates MITSUBISHI KASEI CORPORATION (JP) 1981-10-07 EP disclosed
US-4271261-A PHOTOSENSITIVE POLYMER MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1981-06-02 US disclosed
EP-0013006-A1 Developer composition for lithographic printing plates MITSUBISHI KASEI CORPORATION (JP) 1980-07-09 EP disclosed
US-4186122-A POLYESTER-AMIDE-IMIDE COPOLYMERS HITACHI CHEMICAL COMPANY, LTD. (JP) 1980-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12588446-B2 Surface treatment composition and method for producing wafer SGMS1, SGMS2, SMURF1 ALDH1A1 2890/4885TSHR 2614/4885HSD17B10 2560/4885
US-12570865-B2 Active energy ray-curable inkjet printing ink composition ACP1, HPD, ACVRL1 ALDH1A1 351/4885TSHR 4474/4885HSD17B10 457/4885
US-20260018421-A1 SUBSTRATE PROCESSING METHOD, AND SUBSTRATE MANUFACTURING METHOD ESPL1, SMS, SGMS1 ALDH1A1 1476/4885TSHR 2961/4885HSD17B10 2470/4885
US-20260125594-A1 QUANTUM DOT-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME ITGA6, STRA6, ILK ALDH1A1 1562/4885TSHR 1369/4885HSD17B10 4330/4885
US-12630727-B2 Photocurable inkjet printing ink composition OR10J3, TAS2R20, ILK ALDH1A1 41/4885TSHR 2979/4885HSD17B10 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.